Mixed Views on E-Cigarettes Prompt EU Regulatory Directive

Introduction: The emergence of e-cigarettes has helped offset the impact on consumers caused by smoking bans in public places in many countries. Because e-cigarettes do not contain tar, suspended particles, and certain other harmful components found in cigarettes, they have also been promoted as a smoking cessation aid.

News from Heated Tobacco Information Network: E-cigarettes, also known as electronic cigarettes, have helped offset the impact on consumers caused by smoking bans in public places in many countries. Because e-cigarettes do not contain tar, suspended particles, and certain other harmful components found in cigarettes, they have also been promoted as a smoking cessation aid. As e-cigarettes continue to expand globally, the number of users has increased significantly. However, due to the long-standing lack of systematic clinical trial data, countries hold mixed views on e-cigarettes. Some countries consider e-cigarettes illegal, while others require them to meet pharmaceutical standards before they can be sold as smoking cessation products. Australia strictly prohibits the sale of e-cigarettes containing nicotine. In March this year, following New York and Chicago, Los Angeles in the United States also decided to ban e-cigarette use in certain public places. Although the 28 EU member states have differing attitudes toward e-cigarettes, in response to rising sales and a rapidly expanding user base, the EU published Directive 2014/40/EU in its Official Journal on April 29, 2014, regulating tobacco-related products and bringing e-cigarettes within the scope of regulation. In principle, the new EU directive allows disposable (single-use), cartridge-based (used with single-use cartridges), and refillable e-cigarettes (equipped with refill containers) to be sold on the market, and it provides detailed specifications on related technical standards and sales conditions. As a guiding legal act, the directive allows member states to decide whether to classify e-cigarettes as consumer products or pharmaceuticals, and to establish authorization mechanisms, testing, and certification requirements based on relevant domestic resolutions. At the same time, the directive also introduces additional safeguards, stipulating that when the competent authorities of member states have reasonable grounds to believe that e-cigarettes pose a serious health risk, they may adopt temporary measures to restrict or prohibit their market activities.

China has undertaken manufacturing for multiple e-cigarette brands, and in recent years, as vaping products have continued to rise in popularity, export output has increased substantially. Experts say that the emergence of e-cigarettes has, to some extent, been replacing part of the market share of traditional cigarettes. Yet the potential and unknown risks of e-cigarettes remain a difficult issue for countries around the world to weigh. Domestic e-cigarette manufacturers, within the limits of their own technology, should closely monitor international developments while also building industry alliances. Through continuous testing and experimentation, they should improve product formulations and reduce the possibility of e-cigarette-related incidents as much as possible. By comparing the actual harms of traditional cigarettes, they can further highlight the health advantages of e-cigarettes. In addition, companies should eliminate false advertising and, during the export process, proactively communicate with overseas clients and actively provide relevant documents and information.